EXECUTIVE SUMMARY NDA[removed]New Formulation Isotretinoin Applicant:

First Page		Document Content
Date: 2000-09-15 06:11:55 Medicine Health Pharmacology Clinical research Pharmaceutical sciences Acne vulgaris Clinical trial Anti-acne preparations Isotretinoin Retinoids		EXECUTIVE SUMMARY NDA[removed]New Formulation Isotretinoin Applicant: Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 74,55 KB Share Document on Facebook